[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100546738":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":21,"centralContacts":22,"locations":28,"responsibleParty":50,"collaborators":21,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":21,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":21,"enrollmentInfo":63,"targetDuration":21,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":74,"overallStatus":30,"whyStopped":21,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Icahn School of Medicine at Mount Sinai","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"HIV-associated Chronic Pain Patients","The participants will be enrolled into an open label arm to determine feasibility and useability of the combination device.",[12],"Device: Virtual Reality headset",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","Virtual Reality headset","Self-hypnosis software in a Virtual Reality headset. This is the development of software that provides a self-hypnosis experience that can be inserted into any virtual reality device.",[9],[20],"OculusGo™",null,[23],{"name":24,"role":25,"phone":26,"phoneExt":21,"email":27},"Mary Catherine George, PhD","CONTACT","646-808-6231","mary-catherine.george@mssm.edu",[29],{"facility":5,"status":30,"city":31,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"RECRUITING","New York","10029","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-74.00597,40.71427,{"lat":39,"lon":38},[42,43,47],{"name":24,"role":25,"phone":26,"phoneExt":21,"email":27},{"name":44,"role":25,"phone":45,"phoneExt":21,"email":46},"Shatabdi Joshi, MS","212-241-9951","shatabdi.joshi@mssm.edu",{"name":48,"role":49,"phone":21,"phoneExt":21,"email":21},"'David Dorfman","SUB_INVESTIGATOR",{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":21,"oldOrganization":21},"PRINCIPAL_INVESTIGATOR","Mary Catherine George","Director Clinical Research","100546738","virtual-reality-vr-self-hypnosis-software-100546738",false,"NCT06398847","Virtual Reality (VR) Self-Hypnosis Software","An Open-label Study of Self-hypnosis Software for Virtual Reality for the Treatment of HIV-associated Chronic Pain - a Development and Usability Study","Patient Eligibility\n\nInclusion Criteria:\n\n* Adults age ≥18\n* Confirmed diagnosis of HIV, currently on a stable antiretroviral regimen ≥ 90 days.\n* Documentation of chronic pain associated with HIV for≥90 days\n* Stable pain management regimen ≥90 days, or no pain treatments ≥90 days\n* Average pain intensity of 3 or greater on the NRS of the mean daily scores reported between Visit 1 and Visit 2\n* Access to the internet via smartphone, computer, or tablet 7. Fluent in English\n* Capable of giving informed consent and willingness to comply with study procedures.\n\nExclusion Criteria:\n\n* A co-occurring medical or psychiatric condition which would make participation in the study or complicate measurement of changes associated with the intervention.\n* Concurrent participation in another investigational protocol for pain treatment\n* A psychiatric disorder, medical condition, or other life circumstance, which in the opinion of the PI, would contraindicate attendance at sessions, or make it unlikely that the participant could successfully complete the study procedures.\n* Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, or other neurological conditions contraindicating the use of virtual reality devices.\n* A medical condition predisposing prospective participant to nausea or dizziness 6. Lack of stereoscopic vision or severe hearing impairment\n* Injury to eyes, face, or neck that impedes using the VR device\n* If participant has access to personal VR gear for gaming or other purposes at home, participant fails to agree not to use these personal VR gear during the course of the protocol.\n* Currently pregnant or planning to become pregnant during the study period","ALL","18 Years",{"count":64,"type":65},25,"ESTIMATED","INTERVENTIONAL",[68],"NA","This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGo™) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sinai Innovations.",[71,72,73],"Musculoskeletal Pain","Neuropathic Pain","Neuralgia",[75,76,77,78],"HIV chronic pain","Self-hypnosis","virtual reality software","non-drug treatment for chronic pain","2026-03-27",{"date":81,"type":82},"2026-04-02","ACTUAL",{"date":84,"type":82},"2026-03-26",{"date":86,"type":65},"2026-06-30",{"name":5,"class":6},1]